News | Nipro

R&D at Nipro

3% of Japan’s GDP goes to Research & Development. The strategy for Japan’s R&D approach has changed over the years. What does Nipro place emphasis on in its strategy?

Synergies within Nipro

Introducing the synergy between medical devices, pharmaceutical drugs and pharmaceutical packaging.

Nipro assumes its role and establishes a stable supply

To establish a stable supply requires spending a significant amount for the production processes.